<DOC>
	<DOCNO>NCT00954564</DOCNO>
	<brief_summary>RATIONALE : Gathering information time joint pain stiffness postmenopausal woman early-stage breast cancer receive aromatase inhibitor may help doctor plan treatment help patient live comfortably . PURPOSE : This observational epidemiologic cohort design study arthralgia , patient-reported outcome , medication adherence postmenopausal woman early-stage breast cancer receive aromatase inhibitor .</brief_summary>
	<brief_title>Joint Pain Medication Adherence Postmenopausal Women Receiving Aromatase Inhibitors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Estimate incidence , time onset , prevalence , clinical demographic predictor arthralgia post-menopausal woman early-stage breast cancer receive aromatase inhibitor ( AI ) . - Chart trajectory arthralgia symptom severity course AI treatment patient . Secondary - Measure impact arthralgia sleep quality , depression , physical function patient . - Develop roster current physician-advised prescribed treatment , include self-management technique use AI-induced arthralgia , intervention development . OUTLINE : Patients complete questionnaire joint pain stiffness , sleep , depression , physical function , medication treatment , exercise social support , demographic , comorbidities , body mass index ( BMI ) , performance status baseline periodically approximately 1 year begin aromatase inhibitor ( AI ) therapy . Patient medical record review comorbidities , BMI , use prior hormone replacement therapy , vitamin D level deficiency , performance status , histological stage , prior treatment , medication baseline periodically approximately 1 year begin AI therapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<mesh_term>Aromatase Inhibitors</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Planning begin aromatase inhibitor ( AI ) therapy take few 10 dos adjuvant AI therapy Hormonereceptor status specify PATIENT CHARACTERISTICS : Postmenopausal ECOG performance status 01 Able understand respond question English No condition would impair ability provide inform consent No nonbreast cancer condition PRIOR CONCURRENT THERAPY : See Disease Characteristics No 9 prior dos AI</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>arthralgia</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>